S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NBY NovaBay Pharmaceuticals Inc New

0.5999

0.0194 (3.34%)

Mar 06 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals Inc New News

Form PRE 14A - Other preliminary proxy statements
Tuesday 18 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 6 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Thursday 23 January 2025 (1 month ago) • Business Wire

Form 8-K - Current report
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (3 months ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Thursday 19 December 2024 (3 months ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 11 December 2024 (3 months ago) • Edgar (US Regulatory)

More NovaBay Pharmaceuticals Inc New News Articles

Tonix Pharmaceuticals

Mullen Automotive

RespireRx Pharmaceuticals (CE)

Accredited Solutions (PK)

Kraig Biocraft Laborator... (QB)

TPT Global Tech (PK)

Impact Fusion (PK)

CyberFuels (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions